[1]刘 芸,马凯婷,袁晓悦,等.香芹酚对STZ诱导的1型糖尿病小鼠主动脉血管重构的影响[J].中国药理学通报,2018,(10):1439-1443.[doi:10.3969/j.issn.1001-1978.2018.10.022]
 LIU Yun,MA Kai-ting,YUAN Xiao-yue,et al.Effect of carvacrol on aortic vascular remodeling of STZ-induced type 1 diabetic mice[J].Chinese Pharmacological Bulletin,2018,(10):1439-1443.[doi:10.3969/j.issn.1001-1978.2018.10.022]
点击复制

香芹酚对STZ诱导的1型糖尿病小鼠主动脉血管重构的影响()
分享到:

《中国药理学通报》[ISSN:/CN:]

卷:
期数:
2018年10期
页码:
1439-1443
栏目:
论著
出版日期:
2018-09-26

文章信息/Info

Title:
Effect of carvacrol on aortic vascular remodeling of STZ-induced type 1 diabetic mice
文章编号:
1001-1978(2018)10-1439-05
作者:
刘 芸12马凯婷12袁晓悦12侯 宁1
广州医科大学1.药学院药理学教研室、2.基础医学实验教学中心机能实验室,广东 广州 511436
Author(s):
LIU Yun12 MA Kai-ting12 YUAN Xiao-yue12 HOU Ning1
1.Dept of Pharmacology, School of Pharmaceutical Sciences; 2.Medical Functional Lab, Experimental Teaching Center of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, China
关键词:
香芹酚 糖尿病 链脲佐菌素 血管重构 细胞表型 PI3K/Akt
Keywords:
carvacrol diabetes streptozotocin vascular remodeling cell phenotype PI3K/Akt
分类号:
R-332; R284.1; R322.121; R587.1; R587.2; R977.6
DOI:
10.3969/j.issn.1001-1978.2018.10.022
文献标志码:
A
摘要:
目的 观察香芹酚(carvacrol,CAR)对糖尿病小鼠主动脉血管重构的影响。方法 腹腔注射链脲佐菌素( streptozotocin,STZ)建立1型糖尿病C57BL/6小鼠模型,成模小鼠随机分为糖尿病组、CAR低、高剂量组(10、20 mg·kg-1),以同周龄、同性别正常小鼠为对照组。糖尿病组和对照组每天腹腔注射生理盐水,CAR给药组每天腹腔注射CAR,每周测量体质量和随机血糖。给药6周后处死小鼠,收集主动脉,检测主动脉血管形态,细胞表型转变标志物α-actin、Ki67的表达,以及PDK1、Akt的磷酸化水平。结果 CAR可明显降低糖尿病小鼠的随机血糖,增加糖尿病小鼠主动脉Ki67的表达,以及PDK1、Akt的磷酸化水平,抑制α-actin的表达。结论 CAR可降低1型糖尿病小鼠血糖,改善主动脉血管重构,对糖尿病及其并发的血管疾病有一定的治疗作用。
Abstract:
Aim To investigate the effect of carvacrol on aortic vascular remodeling in diabetic mice.Methods Diabetes was induced by intraperitoneal injection of streptozotocin into male mice at the dose of 45 mg·kg-1 body weight.Mice were randomly divided into three groups and age matched male C57BL/6 mice were used as normal control.The mice in diabetic group and control group were intraperitoneally injected with physiological saline once daily.The mice in carvacrol-administered group were intraperitoneally injected with carvacrol at the dose of 10 or 20 mg·kg-1 body weight respectively once daily.The body weight and random blood glucose were measured weekly.The mice were sacrificed after six weeks of administration, and the aortas were collected for detection of morphology, expression of α-actin and Ki67, and phosphorylation levels of PDK1 and Akt.Results Carvacrol significantly reduced the random blood glucose of diabetic mice, increased the expression of Ki67 and the phosphorylation levels of PDK1 and Akt, whereas it inhibited the expression of α-actin in aorta of diabetic mice.Conclusions Carvacrol has anti-diabetic property and can improve aortic vascular remodeling, which has the potential for development into a drug to prevent hyperglycemia and its complications of vascular diseases.

参考文献/References:

[1] Tardif K, Hertig V, Dumais C, et al.Nestin downregulation in rat vascular smooth muscle cells represents an early marker of vascular disease in experimental type I diabetes[J].Cardiovasc Diabetol, 2014, 13:119.
[2] Xiao Y, Li B, Liu J, et al.Carvacrol ameliorates inflammatory response in interleukin 1β-stimulated human chondrocytes[J].Mol Med Rep, 2018, 17(3): 3987-92.
[3] Alvarenga E M, Souza L K, Araújo T S, et al.Carvacrol reduces irinotecan-induced intestinal mucositis through inhibition of inflammation and oxidative damage via TRPA1 receptor activation[J].Chem Biol Interact, 2016, 260: 129-40.
[4] Jung C Y, Kim S Y, Lee C.Carvacrol targets AXL to inhibit cell proliferation and migration in non-small cell lung cancer cells[J].Anticancer Res, 2018, 38(1): 279-86.
[5] Sokolik C G, Ben-Shabat-Binyamini R, Gedanken A, et al.Proteinaceous microspheres as a delivery system for carvacrol and thymol in antibacterial applications[J].Ultrason Sonochem, 2018, 41: 288-96.
[6] Earley S, Gonzales A L, Garcia Z I.A dietary agonist of transient receptor potential cation channel V3 elicits endothelium-dependent vasodilation[J].Mol Pharmacol, 2010, 77(4): 612-20.
[7] Suntres Z E, Coccimiglio J, Alipour M.The bioactivity and toxicological actions of carvacrol[J].Crit Rev Food Sci Nutr, 2015, 55(3): 304-18.
[8] Brown A, Reynolds L R, Bruemmer D.Intensive glycemic control and cardiovascular disease: an update[J].Nat Rev Cardiol, 2010, 7(7): 369-75.
[9] Bayramoglu G, Senturk H, Bayramoglu A, et al.Carvacrol partially reverses symptoms of diabetes in STZ-induced diabetic rats[J].Cytotechnology, 2014,66(2): 251-7.
[10] Deng W, Lu H, Teng J.Carvacrol attenuates diabetes-associated cognitive deficits in rats[J].J Mol Neurosci, 2013, 51(3): 813-9.
[11] 侯 宁,麦云珮,张淑允,等.香芹酚对STZ诱导的1型糖尿病小鼠糖脂代谢的影响[J].中国药理学通报, 2016, 32(9): 1306-10.
[11] Hou N, Mai Y P, Zhang S Y, et al.Effect of CAR on STZ-induced type 1 diabetic mice[J].Chin Pharmacol Bull, 2016, 32(9): 1306-10.
[12] Hien T T, Turczyńska K M, Dahan D, et al.Elevated glucose levels promote contractile and cytoskeletal gene expression in vascular smooth muscle via Rho/protein kinase C and actin polymerization[J].J Biol Chem, 2016, 291(7): 3552-68.
[13] Schmidt L, Carrillo-Sepulveda M A.Toll-like receptor 2 mediates vascular contraction and activates RhoA signaling in vascular smooth muscle cells from STZ-induced type 1 diabetic rats[J].Pflugers Arch, 2015,467(11): 2361-74.
[14] 孙晓慧,王 燕,牟艳玲.2型糖尿病大鼠心肌PI3K/Akt/mTOR信号通路的改变及Sirt1的调控机制研究[J].中国药理学通报,2017,33(6):793-8.
[14] Sun X H, Wang Y, Mou Y L.Alteration of PI3K/Akt/mTOR signaling during developmentof diabetic cardiomyopathy and regulation of SIRT1[J].Chin Pharmacol Bull, 2017, 33(6): 793-8.
[15] Hamamdzic D, Fenning R S, Patel D, et al.Akt pathway is hypoactivated by synergistic actions of diabetes mellitus and hypercholesterolemia resulting in advanced coronary artery disease[J].Am J Physiol Heart Circ Physiol, 2010,299(3): H699-706.

相似文献/References:

[1]王蕾,朱迪娜,吕翠,等.甲基乙二醛与相关疾病的研究进展[J].中国药理学通报,2014,(04):456.
 WANG Lei,ZHU Di-na,L Cui,et al.Research advancement of methylglyoxal in related diseases[J].Chinese Pharmacological Bulletin,2014,(10):456.
[2]张 松,朱 琳,郝 军,等.血清TNF-α升高对糖尿病肾脏脂质积聚的影响研究[J].中国药理学通报,2014,(08):1161.
 ZHANG Song,ZHU Lin,HAO Jun,et al.Effect of increased serum TNF-α on lipid accumulation in kidney of diabetes[J].Chinese Pharmacological Bulletin,2014,(10):1161.
[3]徐 婧,朱林卉,王德彬,等.齐墩果酸衍生物对胰岛素抵抗的改善作用及机制[J].中国药理学通报,2014,(11):1585.
 XU Jing,ZHU Lin-hui,WANG De-bin,et al.Effect of oleanolic acid derivatives on improving insulin resistance and its molecular mechanism[J].Chinese Pharmacological Bulletin,2014,(10):1585.
[4]席晓慧,王福文,王 燕,等.早期糖尿病大鼠心肌Wnt/β-catenin信号通路的变化[J].中国药理学通报,2015,(03):363.[doi:10.3969/j.issn.1001-1978.2015.03.014]
 XI Xiao-hui,WANG Fu-wen,WANG Yan,et al.Alteration of Wnt/β-catenin signaling pathway in early diabetic rat myocardium[J].Chinese Pharmacological Bulletin,2015,(10):363.[doi:10.3969/j.issn.1001-1978.2015.03.014]
[5]易 云,吴 琴,黄莉萍,等.氧化苦参碱对高糖毒性下血管内皮细胞的保护作用[J].中国药理学通报,2015,(04):499.
 YI Yun,WU Qin,HUANG Li-ping,et al.Protective effect of oxymatrine on vein endothelial cell from glucose toxicity[J].Chinese Pharmacological Bulletin,2015,(10):499.
[6]王栋栋,何素梅,张冠英,等.大黄游离蒽醌对糖尿病大鼠心肌纤维化的作用[J].中国药理学通报,2015,(04):509.
 WANG Dong-dong,HE Su-mei,ZHANG Guan-ying,et al.Effects of FAR on myocardial fibrosis of diabetic rats[J].Chinese Pharmacological Bulletin,2015,(10):509.
[7]黄 波,江 芬,薛 莱,等.PPARβ在虎杖苷抗高糖高胰岛素诱导心肌肥大中的作用[J].中国药理学通报,2015,(09):1264.[doi:10.3969/j.issn.1001-1978.2015.09.017]
 HUANG Bo,JIANG Fen,XUE Lai,et al.PPARβ-related signal pathway involves in the effect of polydatin on high glucose-and insulin-induced cardiomyocyte hypertrophy[J].Chinese Pharmacological Bulletin,2015,(10):1264.[doi:10.3969/j.issn.1001-1978.2015.09.017]
[8]马 航,胡慭然,邹宗尧,等.黄连生物碱降糖作用研究及构效关系初探[J].中国药理学通报,2015,(11):1575.[doi:10.3969/j.issn.1001-1978.2015.11.019]
 MA Hang,HU Yin-ran,ZOU Zong-yao,et al.Preliminary evaluation of antihyperglycemic effect ofRhizoma Coptidis alkaloids and their structure-activity relationships[J].Chinese Pharmacological Bulletin,2015,(10):1575.[doi:10.3969/j.issn.1001-1978.2015.11.019]
[9]钱卫斌,钱秋海.糖肝康对TAA致糖尿病模型大鼠肝损伤肝脏TLR4表达的影响[J].中国药理学通报,2016,(02):295.[doi:10.3969/j.issn.1001-1978.2016.02.030]
 QIAN Wei-bin,QIAN Qiu-hai.Effect of Tanggankang on immunohistochemical expression of TLR4 in acute damaged liver rat model[J].Chinese Pharmacological Bulletin,2016,(10):295.[doi:10.3969/j.issn.1001-1978.2016.02.030]
[10]王 欢,汪应红,田远耀,等.酸敏感离子通道1a在高糖环境下肝纤维化发病中的作用研究[J].中国药理学通报,2016,(03):384.[doi:10.3969/j.issn.1001-1978.2016.03.017]
 WANG Huan,WANG Ying-hong,TIAN Yuan-yao,et al.Effect of ASIC1a on hepatic fibrosis under high glucose[J].Chinese Pharmacological Bulletin,2016,(10):384.[doi:10.3969/j.issn.1001-1978.2016.03.017]
[11]麦云珮,张淑允,窦纪梁,等.香芹酚对STZ诱导的1型糖尿病小鼠糖脂代谢的影响[J].中国药理学通报,2016,(09):1306.[doi:10.3969/j.issn.1001-1978.2016.09.023]
 MAI Yun-pei,ZHANG Shu-yun,DOU Ji-liang,et al.Effect of CAR on STZ-induced type 1 diabetic mice[J].Chinese Pharmacological Bulletin,2016,(10):1306.[doi:10.3969/j.issn.1001-1978.2016.09.023]

备注/Memo

备注/Memo:
收稿日期:2018-06-08,修回日期:2018-07-20
基金项目:国家自然科学基金资助项目(No 81402928); 广东省科技计划项目(No 2014A020212607); 广州市教育科研项目(No 1201630448,1201610064)
作者简介:刘 芸(1985-),女,博士,讲师,研究方向:心血管药理学,E-mail:liuyun195@sina.com;
侯 宁(1981-),女,博士,教授,硕士生导师,研究方向:糖尿病药理学,通讯作者,Tel:020-37103630,E-mail:houning-2003@163.com
更新日期/Last Update: 2018-08-26